SNDX - Syndax Pharmaceuticals Inc

QQQ $ 617.50 $ 6.52 (1.07 %)

DIA $ 472.45 $ 4.92 (1.05 %)

SPY $ 677.25 $ 5.49 (0.82 %)

TLT $ 91.47 $ 0.04 (0.04 %)

GLD $ 378.59 $ -1.27 (-0.34 %)

Previous Close

$ 13.53

Open

$ 15.04

Bid

$ 13.00 x 500

Ask

$ 13.90 x 250

Day's Range

$ 13.03 - $ 15.79

52 Week Range

$ 8.58 - $ 22.50

Volume

14,951,258

Average Volume

Market Cap

1.17B

Beta (5Y Monthly)

$ 0.84

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-04-2025	06-30-2025	10-Q
2	05-05-2025	03-31-2025	10-Q
3	03-03-2025	01-01-1970	10-K
4	11-05-2024	09-30-2024	10-Q
5	08-01-2024	06-30-2024	10-Q
6	05-08-2024	03-31-2024	10-Q
7	02-27-2024	12-31-2023	10-K
8	11-02-2023	09-30-2023	10-Q
9	08-03-2023	06-30-2023	10-Q
10	05-08-2023	03-31-2023	10-Q
11	02-28-2023	12-31-2022	10-K
12	11-03-2022	09-30-2022	10-Q
13	08-08-2022	06-30-2022	10-Q
14	05-09-2022	03-31-2022	10-Q
15	03-01-2022	12-31-2021	10-K
16	11-15-2021	09-30-2021	10-Q
17	08-09-2021	06-30-2021	10-Q
18	05-11-2021	03-31-2021	10-Q
19	03-12-2021	12-31-2020	10-K
20	11-05-2020	09-30-2020	10-Q
21	08-06-2020	06-30-2020	10-Q
22	05-07-2020	03-31-2020	10-Q
23	03-05-2020	12-31-2019	10-K
24	11-07-2019	09-30-2019	10-Q
25	08-07-2019	06-30-2019	10-Q
26	05-08-2019	03-31-2019	10-Q
27	03-07-2019	12-31-2018	10-K
28	11-05-2018	09-30-2018	10-Q
29	08-08-2018	06-30-2018	10-Q
30	05-09-2018	03-31-2018	10-Q
31	03-08-2018	12-31-2017	10-K
32	11-08-2017	09-30-2017	10-Q
33	08-10-2017	06-30-2017	10-Q
34	05-09-2017	03-31-2017	10-Q
35	03-14-2017	12-31-2016	10-K
36	11-14-2016	09-30-2016	10-Q
37	08-15-2016	06-30-2016	10-Q
38	05-16-2016	03-31-2016	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Why Is Syndax Stock Down Today?
10/24/2025 20:07:49

Shares of Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) are trading lower Friday following approval of one of its treatments fro...

Syndax Pharmaceuticals Shares Move Lower D...
10/24/2025 18:29:20

Syndax Pharmaceuticals Shares Resume Trade
10/24/2025 18:20:23

Trading Halt: Halt status updated at 2:15:...
10/24/2025 18:15:04

$fda-approves-revumenib-for-relapsed-or-refractory-acute-myeloid-leukemia-with-a-susceptible-npm1-mutation$

FDA Approves Revumenib For Relapsed Or Ref...
10/24/2025 17:08:47

https://www.fda.gov/drugs/resources-information-approved-drugs/

Trading Halt: Halted at 12:56:17 p.m. ET -...
10/24/2025 16:56:21

Where Syndax Pharmaceuticals Stands With A...
10/16/2025 14:02:42

HC Wainwright & Co. Assumes Syndax Pharmac...
10/16/2025 10:49:31

HC Wainwright & Co. analyst Andres Y. Maldonado assumes Syndax Pharmaceuticals (NASDAQ:SNDX) with a Buy rating and annou...

BTIG Reiterates Buy on Syndax Pharmaceutic...
09/19/2025 17:11:10

BTIG analyst Justin Zelin reiterates Syndax Pharmaceuticals (NASDAQ:SNDX) with a Buy and maintains $56 price target.

$syndaxs-revuforj-revumenib-added-to-nccn-guidelines-as-category-2a-treatment-for-relapsedrefractory-npm1-mutated-aml-supported-by-augment-101-trial-fda-priority-review-snda-decision-due-oct-25-2025$

Syndax's Revuforj (Revumenib) Added To NCC...
09/19/2025 11:02:18

Stifel Reinstates Buy on Syndax Pharmaceut...
09/10/2025 12:33:48

Stifel analyst Bradley Canino reinstates Syndax Pharmaceuticals (NASDAQ:SNDX) with a Buy and announces $44 price target.

Goldman Sachs Maintains Buy on Syndax Phar...
09/05/2025 14:52:24

Goldman Sachs analyst Corinne Johnson maintains Syndax Pharmaceuticals (NASDAQ:SNDX) with a Buy and raises the price target ...

syndax-gains-attention-with-strong-drug-portfolio-path-to-leukemia-market-growth

Syndax Gains Attention With Strong Drug Po...
09/04/2025 19:17:43

Syndax shares gained support after Guggenheim issued a Buy rating, citing strong Q2 results, Revuforj growth, and long-term pro...

this-hubspot-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday

This HubSpot Analyst Begins Coverage On A ...
09/04/2025 14:14:40

Deep Dive Into Syndax Pharmaceuticals Stoc...
09/04/2025 12:02:06

Guggenheim Initiates Coverage On Syndax Ph...
09/04/2025 11:43:20

Guggenheim analyst Bradley Canino initiates coverage on Syndax Pharmaceuticals (NASDAQ:SNDX) with a Buy rating and announces...

Citigroup Maintains Buy on Syndax Pharmace...
08/05/2025 17:59:42

Citigroup analyst Yigal Nochomovitz maintains Syndax Pharmaceuticals (NASDAQ:SNDX) with a Buy and raises the price target fr...

BTIG Maintains Buy on Syndax Pharmaceutica...
08/05/2025 16:29:27

BTIG analyst Justin Zelin maintains Syndax Pharmaceuticals (NASDAQ:SNDX) with a Buy and raises the price target from $43 to ...

Syndax Pharmaceuticals Q2 EPS $(0.83) Beat...
08/04/2025 20:04:32

Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.83) per share which beat the analyst consensus estimate o...

Earnings Scheduled For August 4, 2025
08/04/2025 08:32:29